Skip to main content
. Author manuscript; available in PMC: 2021 Feb 4.
Published in final edited form as: Semin Cancer Biol. 2018 May 9;52(Pt 2):94–106. doi: 10.1016/j.semcancer.2018.05.001

Figure 1. Targeting CSCs to effectively treat cancer.

Figure 1.

The inability of conventional therapies to target CSCs represents a significant factor contributing to current cancer treatment failure. A combination of conventional therapy and CSC-specific therapy is expected to achieve a better clinical outcome by inhibiting tumor regrowth mediated by drug-resistant CSCs.